These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9706178)
1. Patients who pay out-of-pocket receive lower-cost drugs. Am J Health Syst Pharm; 1998 Aug; 55(15):1556-8. PubMed ID: 9706178 [No Abstract] [Full Text] [Related]
2. The association of insurance type with costs of dispensed drugs. Mott DA; Kreling DH Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015 [TBL] [Abstract][Full Text] [Related]
3. State Medicaid pharmacy payments and their relation to estimated costs. Adams EK; Kreling DH; Gondek K Health Care Financ Rev; 1994; 15(3):25-42. PubMed ID: 10137796 [TBL] [Abstract][Full Text] [Related]
5. Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available. Socal MP; Bai G; Anderson GF JAMA Intern Med; 2019 Jun; 179(6):832-833. PubMed ID: 30882842 [TBL] [Abstract][Full Text] [Related]
6. The effects of copayments and generic substitution on the use and costs of prescription drugs. Smith DG Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607 [TBL] [Abstract][Full Text] [Related]
7. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses. Donohue JM Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937 [No Abstract] [Full Text] [Related]
8. Impact of brand drug discount cards on private insurer, government and patient expenditures. Law MR; Chan FKI; Harrison M; Worthington HC CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357 [TBL] [Abstract][Full Text] [Related]
9. Employers push to manage prescription drug costs. Frieden J Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119 [No Abstract] [Full Text] [Related]
10. Out-of-pocket costs to users: medicine options for hypertension. Arredondo A Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138 [No Abstract] [Full Text] [Related]
11. Datawatch. Rx coverage and consumer ads: a costly combo. Bus Health; 1998 Oct; 16(10):68. PubMed ID: 10185119 [No Abstract] [Full Text] [Related]
12. [The patients' cost of the montelukast therapy due to the generic substitution]. Répásy B; Endrei D; Zemplényi A; Ágoston I; Boncz I Orv Hetil; 2018 Apr; 159(17):682-687. PubMed ID: 29681174 [TBL] [Abstract][Full Text] [Related]
13. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
15. Drug pricing in AFP--how much does a drug cost? Siwek J Am Fam Physician; 2010 Jan; 81(2):125. PubMed ID: 20082507 [No Abstract] [Full Text] [Related]
16. Increasing generic drug use in Medicare Part D: the role of government. Kohl H; Shrank WH J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887 [No Abstract] [Full Text] [Related]
17. Is There a Cure for High Drug Prices? A Special Investigation From Consumer Reports Best Buy Drugs. Consum Rep; 2016 Aug; 81(8):52-60. PubMed ID: 27459753 [No Abstract] [Full Text] [Related]
18. Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components. Rabbani A; Alexander GC Am J Hypertens; 2008 May; 21(5):509-13. PubMed ID: 18437141 [TBL] [Abstract][Full Text] [Related]
19. Prescription drug costs for Medicare beneficiaries: coverage and health status matter. Stuart B; Shea D; Briesacher B Issue Brief (Commonw Fund); 2000 Jan; (365):1-9. PubMed ID: 11584831 [No Abstract] [Full Text] [Related]
20. Prescription drug benefits: cost management issues for Medicare. Fox PD Health Care Financ Rev; 2003; 25(2):7-21. PubMed ID: 15124374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]